Strong growth, but expansion delays and shareholder dilution cloud the narrative
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Q1 beat guidance; FY27 revenue raised 15-20%. But FY28 Defence target (₹1,000Cr) deferred pending expansion; expansion originally promised by end FY27, now H1 FY28.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong Q1 delivery (+31% revenue, +67% PAT) reflects emerging Defence segment and better product mix. However, expansion delayed 6-9 months reduces FY28 visibility, and FY27 guidance upgrade (15-20% vs 14-15%) is modest. Key risk: shareholder dilution via Defence subsidiary listing at INR375/share, with external investors absorbing upside.
₹1287.4 Cr
Revenue · +30.9% YoY₹67.2 Cr
Reported PAT · +67.4% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew strongly at 31% YoY
METConsolidated revenue ₹1,287.4Cr, +31% reported vs +30.9% actual delivered
PAT grew 67% YoY with higher margins
METConsolidated PAT ₹67.2Cr, +67.4% YoY; NPM 5.2% vs prior 4.0%
EBITDA margins above 10% mark
METConsolidated EBITDA ₹139.66Cr / Revenue ₹1,287.4Cr = 10.8% margin
Defence emerged as major growth engine
METDefence revenue ₹80Cr Q1 with 38% EBITDA; order book ₹307Cr (₹255Cr + ₹52Cr)
Expansion to 250,000 shells by end FY27
MISSDelayed 6-9 months to H1 FY28; financial closure cited as reason
West Asia crisis contained impact
OVERSTATEDManagement acknowledged realization impacted; EBITDA/ton not improved as expected
Earnings quality
What changed since the last call
FY27 revenue growth guidance raised
UpgradePrior: 14-15% FY27 growth (FY26 call). Now: 15-20% (Q1 call). Upgrade reflects Defence ramp and export strength. Q1 delivered 31%, but sustainability uncertain.
Defence expansion timeline pushed
DowngradePrior: expansion complete by end FY27. Now: H1 FY28 (6-9 month delay). Financial closure cited; raises execution risk.
FY28 Defence revenue guidance deferred
WithdrawnPrior: ₹1,000Cr FY28 (₹800Cr shells + ₹200Cr aerospace). Now: 'will update when expansion active.' Effectively withdrawn pending execution.
Defence subsidiary structure finalized
NewExternal capital raise ₹285Cr at INR375/share; parent diluted 10.5%. Multiple analysts questioned shareholder value (subsidiary likely 20-30x EV/EBITDA; parent at discount).
The Q&A
Analysts pressed hard on expansion delays (6-9 months), Defence valuation dilution (external investors at INR375 vs implied ₹5,000Cr equity value for Defence alone), and segment disclosure. Management acknowledged concerns but deferred specifics; tone shifted defensive when cornered on shareholder value.
Defence order details — Shubham, 3A Financial
Answered₹255Cr = ~50,000 shells ERFB (38km range); ₹52Cr = 20,000 shells M107 (18km). Different versions, different unit economics.
Expansion timeline — Shubham, 3A Financial
PartialFinancial closure delays; approvals ongoing. Delays beyond our control.
FY27 revenue guidance — Nishita, Sapphire Capital
PartialWe hope growth sustains in near term. Margins 30-35% range-bound.
Defence subsidiary valuation — Shashank Kanodia, ICICI Securities
DodgedLimited funds; don't want to leverage balance sheet. Future expansion needs; opted for external capital.
Shareholder dilution — Vrushank, Individual Investor
DodgedFinancial advisers recommended this route. Will keep minority concerns in mind.
Realization to ₹9,000/MT — Ritika Sheth, Anantaya Wealth
PartialNot increased much Q1 (impacted by West Asia crisis). Hope to achieve in coming quarters.
FY28 Defence revenue — Rahul Misra, RTL Investments
DodgedWill go forward 6-9 months. Let expansion execute; will update new numbers.
Export growth — Amish Kanani, Knowise
AnsweredUS and Europe. Outlook positive but depends on geopolitical situation evolving daily.
Transmission orders — Amish Kanani, Knowise
AnsweredSolar energy, non-fossil fuel. Transmission lines needed; power transmission gap. Growth expected 3-4 years.
Hydraulic tube capacity — Harsh Vasa, SBI Capital
AnsweredRamped to 60-65% from 50% prior. Rapid expansion expected next quarters.
Guidance
FY27 revenue growth 15-20% (upgraded from 14-15%)
MediumQ1 delivered 31%, but depends on Defence execution and export geopolitical trends. Non-Defence growth opaque.
Defence FY27 revenue ₹300-350Cr (from ₹80Cr Q1 base)
MediumAssumes 4x quarterly ramp; order book ₹307Cr supports. 10-month ₹255Cr execution + ₹52Cr Q1, but near-term clarity limited.
Defence EBITDA margin 30-35% (management conservative guidance)
HighQ1 achieved 38% EBITDA. Management acknowledged conservatism; likely sustainable at 35-40% range.
Consolidated EBITDA margin 10-12% FY27
MediumQ1 achieved 10.8%. Defence ramp and value-added mix should drive to 11-12% range, but West Asia cost pressures offset.
Defence capex ₹400Cr for new 250,000-shell facility
MediumDelayed 6-9 months to H1 FY28. Financial closure ongoing; regulatory approvals pending.
Standalone capex ₹100-150Cr FY27 (GI pipes, precision tubes, hydraulic tubes)
High40,000-45,000 MT capacity addition in value-added segments ramping on track.
Risks the call surfaced
Execution/Regulatory
High250,000 shell capacity originally FY27 end; now H1 FY28 (6-9 month delay). Financial closure and approvals cited. FY28 Defence revenue ₹1,000Cr deferred.
Geopolitical
HighWest Asia crisis impacting petroleum, logistics, packing costs. Realization ₹9,000/MT target not met in Q1 (impacted by volatility). Export growth 53% but dependent on US/EU demand; escalation risks.
Shareholder Value
HighDefence subsidiary raised ₹285Cr at INR375/share (pre-money ₹1,800Cr). Parent shareholders diluted 10.5% in subsidiary. Defence likely 20-30x EV/EBITDA; external investors absorb upside. Multiple analysts questioned value destruction for minorities.
Concentration
Medium₹307Cr Defence order book (₹255Cr + ₹52Cr) = 6% of consolidated revenue, but 38% EBITDA. Two orders; significant reliance on successful execution and future order wins.
Realization
MediumManagement target: ₹9,000/MT by 3-year horizon (from ₹7,000 Q4). Q1 achieved ~₹9,000 but attributed to product mix, not operational efficiency. West Asia crisis dampening. Sustainability at risk.
Management
Score 6/10. Transparent on operations and order details (Defence orders, segment margins, export growth). Evasive on capital allocation (subsidiary valuation, shareholder dilution). Hedged on guidance due to regulatory/approval uncertainties. Mixed. Q1 revenue/PAT beat guidance. But Defence expansion delayed 6-9 months (originally FY27 end). FY28 Defence guidance (₹1,000Cr) deferred. Track record: hit FY27 revenue growth raise (14-15% → 15-20%), but execution delays undermine credibility.
1 · H1 FY28
Defence expansion commercialization; 350,000 shell capacity comes live
2 · Q2-Q3 FY27
Defence ₹255Cr order execution (10-month delivery); proof of ramp capability
3 · 18 months
Defence subsidiary IPO; external investor stake crystallized
Key risk: shareholder dilution via Defence subsidiary listing at INR375/share, with external investors absorbing upside.
Informational and educational content only. Not investment advice.